Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
The summary for the Improved Therapy for Hemophilia and Hereditary Bleeding Disorders grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Improved Therapy for Hemophilia and Hereditary Bleeding Disorders: The National Heart, Lung, and Blood Institute (NHLBI) and the National Hemophilia Foundation (NHF) invite applications for studies that will lead to improved treatment of hemophilia, von Willebrand disease, and other hereditary bleeding disorders with the ultimate goal of finding a cure for bleeding disorders. The objectives of this program are to stimulate research to improve therapy, and enhance understanding of immune response and safety issues related to novel therapeutics, gene transfer or cell based therapies for bleeding disorders.
|Federal Grant Title:||Improved Therapy for Hemophilia and Hereditary Bleeding Disorders|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HL-04-032|
|Type of Funding:||Grant|
|CFDA Descriptions:||Blood Diseases and Resources Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Jan 14, 2020|
|Posted Date:||Jun 21, 2004|
|Creation Date:||Jan 04, 2008|
|Archive Date:||Jan 15, 2005|
|Total Program Funding:|
|Maximum Federal Grant Award:||$250,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Special district governments City or township governments Private institutions of higher education For profit organizations other than small businesses State governments Small businesses Public and State controlled institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
- • Perinatal Stroke (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Advancing Erythroid Cell Biology (R01)
- • Clinical Hematology Research Career Development Program (K12)
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- • Specialized Centers of Clinically Oriented Research (Sccor) in Transfusion Biology and Med...
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)